Wall Street PR

Brendan Byrne

First Priority for Investors? Dump Delcath (DCTH)

Delcath Systems, following weeks of anticipation, announced earlier today that the FDA has accepted the company’s review application for the CHEMOSAT hepatic chemosaturation system. The

First Priority for Investors? Dump Delcath (DCTH)

Delcath Systems, following weeks of anticipation, announced earlier today that the FDA has accepted the company’s review application for the CHEMOSAT hepatic chemosaturation system. The